The FTC’s interim report, titled “Pharmacy Benefit Managers: Ten Powerful Middlemen Inflating Drug Costs and Squeezing Main ...
The FTC opened an investigation in June 2022 into six large PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime ...
Federal regulators plan to sue the top three pharmacy-benefit managers over how they negotiate prices for drugs, including ...
The news comes just one day after the FTC announced it had completed a two-year investigation into the industry. Pharmacy ...
Preparations to sue follow a two-year probe into whether the firms steer patients away from less-expensive medicines.